🚀 VC round data is live in beta, check it out!

AddLife Valuation Multiples

Discover revenue and EBITDA valuation multiples for AddLife and similar public comparables like Tecan Group, MicroPort Scientific, Bausch Health, Mehow Innovative and more.

AddLife Overview

About AddLife

AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in two segments: Labtech and Medtech segments. The Labtech segment, which accounts for the majority of the company revenue, provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service. The Medtech segment includes products related to surgery, thoracic medicine, neurology, wound care, anesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare. AddLife mainly caters to hospitals and laboratories within healthcare, research, colleges, and universities, as well as the food and pharmaceutical industries. Its geographical segments are Sweden, Denmark, Finland, Norway, and Other countries.


Founded

1906

HQ

Sweden

Employees

2.3K

Website

add.life

Financials (LTM)

Revenue: $1B
EBITDA: $193M

EV

$3B

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

AddLife Financials

AddLife reported last 12-month revenue of $1B and EBITDA of $193M.

In the same LTM period, AddLife generated $446M in gross profit, $193M in EBITDA, and $62M in net income.

Revenue (LTM)


AddLife P&L

In the most recent fiscal year, AddLife reported revenue of $1B and EBITDA of $195M.

AddLife expects next 12-month revenue of XXX and NTM EBITDA of XXX

See AddLife forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$1BXXX$1BXXXXXXXXX
Gross Profit$446MXXX$434MXXXXXXXXX
Gross Margin38%XXX37%XXXXXXXXX
EBITDA$193MXXX$195MXXXXXXXXX
EBITDA Margin17%XXX17%XXXXXXXXX
EBIT Margin9%XXX9%XXXXXXXXX
Net Profit$62MXXX$62MXXXXXXXXX
Net Margin5%XXX5%XXXXXXXXX
Net Debt——$377MXXXXXXXXX

Financial data powered by Morningstar, Inc.

AddLife Stock Performance

AddLife has current market cap of $2B, and enterprise value of $3B.

Market Cap Evolution


AddLife's stock price is $18.23.

See AddLife trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$3B$2B0.3%XXXXXXXXX$0.51

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

AddLife Valuation Multiples

AddLife trades at 2.3x EV/Revenue multiple, and 13.7x EV/EBITDA.

See valuation multiples for AddLife and 15K+ public comps

EV / Revenue (LTM)


AddLife Financial Valuation Multiples

As of April 20, 2026, AddLife has market cap of $2B and EV of $3B.

Equity research analysts estimate AddLife's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

AddLife has a P/E ratio of 35.9x.

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$2BXXX$2BXXXXXXXXX
EV (current)$3BXXX$3BXXXXXXXXX
EV/Revenue2.3xXXX2.3xXXXXXXXXX
EV/EBITDA13.7xXXX13.6xXXXXXXXXX
EV/EBIT25.1xXXX24.7xXXXXXXXXX
EV/Gross Profit5.9xXXX6.1xXXXXXXXXX
P/E35.9xXXX35.6xXXXXXXXXX
EV/FCF26.8xXXX21.9xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified AddLife Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

AddLife Margins & Growth Rates

AddLife's revenue in the last 12 month grew by 4%.

AddLife's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.2M for the same period.

AddLife's rule of 40 is 20% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

AddLife's rule of X is 26% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for AddLife and other 15K+ public comps

AddLife Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth4%XXX2%XXXXXXXXX
EBITDA Margin17%XXX17%XXXXXXXXX
EBITDA Growth1%XXX(2%)XXXXXXXXX
Rule of 40—XXX20%XXXXXXXXX
Bessemer Rule of X—XXX26%XXXXXXXXX
Revenue per Employee—XXX$0.5MXXXXXXXXX
Opex per Employee—XXX$0.2MXXXXXXXXX
S&M Expenses to Revenue24%XXX24%XXXXXXXXX
G&A Expenses to Revenue6%XXX6%XXXXXXXXX
R&D Expenses to Revenue1%XXX1%XXXXXXXXX
Opex to Revenue—XXX30%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

AddLife Public Comps

See public comps and valuation multiples for other Medical Devices comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
AddLifeXXXXXXXXXXXXXXXXXX
Tecan GroupXXXXXXXXXXXXXXXXXX
MicroPort ScientificXXXXXXXXXXXXXXXXXX
Bausch HealthXXXXXXXXXXXXXXXXXX
Mehow InnovativeXXXXXXXXXXXXXXXXXX
Sinbon ElectronicsXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

AddLife M&A Activity

AddLife acquired XXX companies to date.

Last acquisition by AddLife was on XXXXXXXX, XXXXX. AddLife acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by AddLife

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

AddLife Investment Activity

AddLife invested in XXX companies to date.

AddLife made its latest investment on XXXXXXXX, XXXXX. AddLife invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by AddLife

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About AddLife

When was AddLife founded?AddLife was founded in 1906.
Where is AddLife headquartered?AddLife is headquartered in Sweden.
How many employees does AddLife have?As of today, AddLife has over 2K employees.
Who is the CEO of AddLife?AddLife's CEO is Fredrik Dalborg.
Is AddLife publicly listed?Yes, AddLife is a public company listed on Nasdaq Stockholm.
What is the stock symbol of AddLife?AddLife trades under ALIF B ticker.
When did AddLife go public?AddLife went public in 2016.
Who are competitors of AddLife?AddLife main competitors are Tecan Group, MicroPort Scientific, Bausch Health, Mehow Innovative.
What is the current market cap of AddLife?AddLife's current market cap is $2B.
What is the current revenue of AddLife?AddLife's last 12 months revenue is $1B.
What is the current revenue growth of AddLife?AddLife revenue growth (NTM/LTM) is 4%.
What is the current EV/Revenue multiple of AddLife?Current revenue multiple of AddLife is 2.3x.
Is AddLife profitable?Yes, AddLife is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of AddLife?AddLife's last 12 months EBITDA is $193M.
What is AddLife's EBITDA margin?AddLife's last 12 months EBITDA margin is 17%.
What is the current EV/EBITDA multiple of AddLife?Current EBITDA multiple of AddLife is 13.7x.
What is the current FCF of AddLife?AddLife's last 12 months FCF is $99M.
What is AddLife's FCF margin?AddLife's last 12 months FCF margin is 8%.
What is the current EV/FCF multiple of AddLife?Current FCF multiple of AddLife is 26.8x.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial